Discovery & Development

New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.

Outsourcing partnerships aim to reduce costs and improve efficiencies, but don't overlook the human elements!

Some patients, particularly children, find medicines unpalatable – and genetics could be the cause.

Industry gurus Frank Romanski, Derek Bush and Kishor Wasan share their views and tips for formulation success.

How is the oral drug delivery field changing to cope with solubility and bioavailability issues?

Formulation continues to challenge the industry, but collaboration and new technologies can tackle the issues head on.

Orally dissolving tablets could be a good match for patients that dislike swallowing tablets.

Can the microbiome predict the likelihood of chemotherapy side effects?

The FDA has approved a pill with the ability to track patient compliance.

The solution to multiple drugs co-existing in a syringe may lie with microparticles